Mr Paras Singh is a consultant urologist with special interests in benign prostatic disease (medical management and minimally invasive therapy - TURiS), prostate cancer (MRI fusion prostate biopsies, template biopsies and active surveillance), urothelial cancers (endoscopic management of bladder cancer and upper tract cancer) and stone diseases. He is also an investigator in prostate and bladder cancer clinical trials.
A potential paradox in prostate adenocarcinoma progression: oestrogen as the initiating driver. Singh PB, Matanhelia SS, Martin FL. Eur J Cancer. 2008 May;44(7):928-36.